REVA to Present at 23rd Annual Piper Jaffray Health Care Conference
November 21 2011 - 9:25PM
REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased
to announce that its Chairman and CEO, Robert Stockman, is
presenting at the 23rd Annual Piper Jaffray Health Care Conference
at 10:30 a.m. US EST on Tuesday, November 29, 2011. The conference
is being held November 29 and 30, 2011 at The New York Palace in
New York City.
The information contained in the presentation has been
previously disclosed. Copies of REVA's recent public presentations
may be accessed under the Investor Relations section of REVA's
website at www.revamedical.com.
About REVA
REVA is a development stage medical device company incorporated
in Delaware, USA, that is focused on the development and eventual
commercialisation of its proprietary, bioresorbable stent products.
REVA's lead product, the ReZolve™ stent, combines REVA's
proprietary stent design with a proprietary polymer that is
metabolised and cleared from the body. The ReZolve stent is
designed to offer full x-ray visibility, clinically relevant sizing
and a controlled and safe resorption rate. In addition, by early
encapsulation of the stent in the artery tissue coupled with the
loss of stent structure over time, the ReZolve stent may reduce the
incidence of late forming blood clots, or thrombosis, a rare but
serious problem associated with drug-eluting metal stents currently
on the market. REVA is in the process of finalising the design of
its ReZolve stent and will require clinical results and regulatory
approval before it can begin selling the ReZolve stent.
The REVA Medical, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=8505
CONTACT: United States
Investor and Media Enquiries:
Cheryl Liberatore
Director, Investor Relations and Marketing
REVA Medical, Inc.
+1 858 966-3045
Australia
Investor Enquiries:
David Allen or Alan Taylor
Inteq Limited
+61 2 9231 3322
Media Enquiries:
Kyahn Williamson & Rebecca Wilson
Buchan Consulting
+ 61 3 9866 4722
Reva Medical (ASX:RVA)
Historical Stock Chart
From Nov 2024 to Dec 2024
Reva Medical (ASX:RVA)
Historical Stock Chart
From Dec 2023 to Dec 2024